You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
福安藥業(300194.SZ):消旋山莨菪鹼、利巴韋林新納入醫保目錄 洛美沙星退出醫保目錄
格隆匯 12-30 16:04

格隆匯 12 月 30日丨福安藥業(300194.SZ)公佈,020年12月28日,國家醫療保障局、人力資源社會保障部發布了《關於印發〈國家基本醫療保險、工傷保險和生育保險藥品目錄〉的通知》【醫保發[2020]53號】,公司下屬子公司產品新納入及退出《醫保目錄》的有關情況公吿如下:

新納入《醫保目錄》產品為消旋山莨菪鹼、利巴韋林。退出《醫保目錄》產品為洛美沙星。

新版《醫保目錄》將於2021年3月1日起正式執行,藥品納入《醫保目錄》將有利於相關產品的市場推廣和銷售,對公司經營業績的影響暫無法估計。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account